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Long-term results after accessory renal artery
coverage during endovascular aortic aneurysm repair
Joshua I. Greenberg, MD, Chelsea Dorsey, MD, Ronald L. Dalman, MD, Jason T. Lee, MD,
E. J. Harris, MD, Tina Hernandez-Boussard, PhD, and Matthew W. Mell, MD, Stanford, Calif
Objective: Current information regarding coverage of accessory renal arteries (ARAs) during endovascular aneurysm
repair (EVAR) is based on small case series with limited follow-up. This study evaluates the outcomes of ARA coverage
in a large contemporary cohort.
Methods: Consecutive EVAR data from January 2004 to August 2010 were collected in a prospective database at a
University Hospital. Patient and aneurysm-related characteristics, imaging studies, and ARA coverage versus preserva-
tion were analyzed. Volumetric analysis of three-dimensional reconstruction computed tomography scans was used to
assess renal infarction volume extent. Long-term renal function and overall technical success of aneurysm exclusion were
compared.
Results:A cohort of 426EVARswas identified. ARAswere present in 69 patients with amean follow-up of 27months (range,
1 to 60 months). Forty-five ARAs were covered in 40 patients; 29 patients had intentional ARA preservation. Patient and
anatomic characteristicswere similar between groups except thatARA coverage patients had shorter aneurysmnecks (P .03).
Renal infarctions occurred in 84% of kidneys with covered ARAs. There was no significant deterioration in long-term
glomerular filtration rate when compared with patients in the control group. No difference in the rate of endoleak, secondary
procedures, or the requirement for antihypertensive medications was found.
Conclusions: This study is the largest to date with the longest follow-up relating to ARA coverage. Contrary to previous
reports, renal infarction after ARA coverage is common. Nevertheless, coverage is well tolerated based upon preservation
of renal function without additional morbidity. These results support the long-term safety of ARA coverage for EVAR
when necessary. ( J Vasc Surg 2012;56:291-7.)
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pCurrent estimates using large administrative data sets
suggest that up to 70% of abdominal aortic aneurysms are
repaired with an endovascular approach.1 Prospective trials
and registries have confirmed the safety and durability of
endovascular aneurysm repair (EVAR), which has pro-
moted widespread implementation.2,3 Device improve-
ments, improved endovascular techniques, and a better
understanding of endoleaks have extended EVAR to more
anatomically and physiologically complex patients.4 Pa-
tients who require accessory renal artery (ARA) coverage in
order to achieve a sound proximal aneurysm seal represent
an important example of this population.
The estimated prevalence of ARAs in humans is 12% to
25%5; however, only arteries inferior to the lowest main
renal artery are surgically relevant during infrarenal repairs.
ARAs may be single or multiple and can arise from the
aneurysm neck or from the aneurysm itself. Historically, the
importance of renal parenchymal preservation during open
aneurysm surgery has been emphasized because postoper-
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doi:10.1016/j.jvs.2012.01.049tive renal insufficiency is markedly associated with worse
utcomes, including mortality.6 ARA reimplantation dur-
ng open surgery is traditionally considered if the artery is
hought to serve a significant volume of renal parenchyma,
f the artery appears sizable, or if a significant volume of
enal parenchyma would otherwise be lost. The Society
f Vascular Surgery Consensus statement for the treatment
f abdominal aortic aneurysm (AAA) recommends for pres-
rvation and reimplantation of a sizable (3 mm) ARA or
hose that supply one-third or more of the renal paren-
hyma, while recognizing that only low-quality evidence
xists to support any one strategy in the management of
RAs in both open and endovascular aortic aneurysm
epair.7 The increasing utilization of EVAR as the primary
ethod of AAA repair, and the necessary loss of renal
arenchyma associated with ARA coverage, has led our
roup and others to question the consequences of this
ractice.
The goal of this study is to determine the effect of ARA
overage on kidney volume and renal function in a contem-
orary cohort. Additional study end points include the effect
f ARA coverage on long-term aneurysm-related complica-
ions. Contemporary assessment of the renal consequences
ssociated with ARA coverage will provide a more accurate
ramework for surgical decisionmaking regarding the eligibil-
ty for EVAR in this patient population.
ETHODS
A retrospective review was performed of data entered
rospectively into an institutional EVAR database follow-
ng Institutional Review Board (IRB) approval. Four hun-
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August 2012292 Greenberg et aldred twenty-six consecutive EVARs were performed be-
tween January 2004 and August 2010, representing our
practice of currently available EVAR technology and latest
generation imaging. Only intact aneurysms as verified by
computed tomography (CT) scan were included; ruptured
and infected aneurysms were excluded. Both asymptomatic
and symptomatic aneurysms are included in the analysis.
Patient demographics, medical histories, and laboratory
results were abstracted from the medical record. Records of
follow-up obtained at alternative centers were reviewed
when available. Glomerular filtration rate (GFR) was esti-
mated using the Modification of Diet in Renal Disease
Equation.8 Preoperative renal insufficiency was defined as
GFR 60 mL/min. CT angiography was performed in all
patients within the first 30 days after EVAR, and at least
annually thereafter. Digital image data were imported into a
three-dimensional workstation (Aquariusnet, TeraRecon,
Foster City, Calif) for analysis and comparison. Largest AAA
Fig 1. Postoperative computed tomography (CT) angi
accessory renal artery (ARA) embolization.diameter was measured for each initial and follow-up scans. vA renal artery was considered eligible for inclusion in
he study if it originated inferior to the lowest ipsilateral
ain renal artery (Fig 1). The main renal artery was iden-
ified based on its destination at the renal hilum and its
ocations relative to standard landmarks. ARAs originating
uperior to the main renal artery were excluded from this
nalysis. Patients with multiple renal arteries and at least
ne covered were included in the covered group, and the
argest covered artery was counted in patients with multiple
overed arteries. Renal infarction volume was calculated
sing the disk-summation method.9 Briefly, the outline of
ach kidney and region of infarction was outlined. The
reas that were circumscribed by a manual contour outline
n each slice were summed for each kidney by multiplying
he number of pixels within the contour, and the area per
ixel. Then, multiplying the total area by the slice thickness,
he kidney volume was computed. The volume of renal
nfarction was compared with the total ipsilateral renal
hy in a patient with (A) and without (B) preoperativeograpolume and calculated as a percent. Early endoleaks were
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Volume 56, Number 2 Greenberg et al 293defined as occurring within 30 days of EVAR; late en-
doleaks were de novo findings on any CT scan after 30 days.
Secondary interventions included any procedure related to
a patient’s infrarenal aortic aneurysm once treated by
EVAR.
All continuous data are presented as mean  SD.
Univariate analysis was performed by using the Fisher exact
test for discrete variables and the t-test for normally distrib-
uted continuous variables as verified by the Shapiro-Wilk
test. Kaplan-Meier curves were generated to compare dif-
ferences in patient survival with log-rank testing. A linear
regression analysis was performed comparing change in
GFR over time versus renal infarction and ARA size. Re-
sults with a P .05 were considered statistically significant.
Statistical analysis was performed using GraphPad Prism
(2007, GraphPad, SanDiego, Calif). Finally, mortality data
were verified against the Social Security Death Index
(SSDI).
RESULTS
Of the study population, 40 (9.4%) patients had ARA
coverage while 29 (6.8%) had ARAs that were left uncov-
ered (Table I). In total, 45 ARAs were covered in 40
patients. Twenty-one (53%) of covered and 15 (53%) of
uncovered patients underwent EVAR with suprarenal fixa-
tion, respectively. Five patients (17.2%) with uncovered
ARAs had more than one ARA (range, 1-3). On average,
there were 1.38 (0.63) and 1.21 (0.49) ARAs in pa-
tients with and without ARA coverage, respectively. All
uncovered ARAs necessarily originated from the aneurysm
neck. In the uncovered group, 24 patients had single ARAs,
four patients had two ARAs, and one patient had three
ARAs. In the ARA coverage group, six patients (15%) had
ARAs originating from the aneurysm sac, and 34 (85%)
had ARAs originating from the aneurysm neck. Thirteen
patients (32.5%) had more than one ARA (range, 1-4); five
patients (12.5%) had coverage of more than one ARA, and
nine arteries were preserved in patients undergoing ARA
Table I. Patient characteristics
Covered
(n  40)
Uncovered
(n  29)
P
value
Mean age (years) 73.7 74 .9216
Female gender 3 (10%) 2 (7%) 1
Abdominal aortic
aneurysm size (mm) 58 59 .6
Comorbidities
Hypertension 33 (82.5%) 24 (82.8%) 1
Coronary artery disease 24 (60%) 15 (51.7%) .62
Hypercholesterolemia 27 (67.5%) 19 (65.5%) 1
Diabetes mellitus 8 (20%) 3 (10.3%) .33
Peripheral artery disease 9 (22.5%) 6 (20.7%) 1
Chronic renal
insufficiency (stage
III/IV) 8 (20%) 10 (34.5%) .27
Solitary kidney 3 (7.5%) 2 (6.9%) 1coverage. 2Aneurysm size, baseline demographics, and comorbidi-
ies were the same between patients with covered and
ncovered ARAs (Table I). All patients received at least one
ostoperative CT scan with intravenous contrast; only two
atients were followed with noncontrast imaging thereafter
related to concern over elevated creatinine).Mean follow-up
as 27 months, and no patients were lost to follow-up in
he study groups.
Thirty-day mortality in the ARA coverage group was
.5% and 0% in the covered and uncovered ARA groups,
espectively (P  1.0). One patient died on postoperative
ay 15 from multisystem organ failure after significant
ntraoperative hemorrhage from an iliac artery injury. At 24
onths, the overall survival was 85% and 90.1% in the
overed and uncovered ARA groups, respectively (P 
19). There were no open surgical conversions of patients
ith ARAs during the study period. Of the seven patients
ith covered ARAs who died in follow-up, the cause of
eath was either unknown or unavailable. One patient died
f pneumonia, and one patient died from a ruptured aneu-
ysm. The cause of death for the three late deaths in patients
ith preserved ARAs was not known.
The number of device components implanted per
atient and the use of contrast was not different between
RA covered and uncovered patients. The mean diame-
er of ARAs in both groups was 3 mm (Table II). Patients
ith ARA coverage had shorter necks compared with
hose without (P  .03). At last follow-up, the mean
hange in GFR was4.3 mL/min for ARA coverage and
0.7 mL/min for ARA preservation (P  .4). Renal
nfarct volume was 12.1% and 0.5% in ARA coverage and
ncovered patients (P .0001), respectively (Table III).
nalysis of covered ARA diameters compared with
hange in GFR demonstrates no trend toward worsening
enal function (Fig 2). Additionally, there was no difference
n antihypertensive agent requirement in either group after
VAR. There was also no difference in the rate of early or late
ndoleaks, or the need for secondary interventions (Table
II).
Two patients underwent preoperative ARA emboliza-
ion prior to EVAR. One had two ARAs: a 4-mm emboli-
ed artery and a 2.5-mm untreated artery. A second patient
ad embolization of a 3.5-mm ARA, which resulted in a
able II. Procedural characteristics
Covered
(n  40)
Uncovered
(n  29)
P
value
ccessory renal
artery/patient 1.38 (0.63) 1.21 (0.49) .23
ccessory renal
artery diameter
(mm) 2.95 (0.71) 2.93 (0.75) .9
eck length (mm) 25.41 (14.69) 33.03 (13.47) .03
evice components 3.15 (0.22) 3.036 (0.15) .69
uprarenal fixation 21 (53%) 15 (53%) 1
ontrast (mL) 109.7 (32.9) 113.6 (41.7) .685% renal infarction, whereas a covered 2-mm artery did
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August 2012294 Greenberg et alnot result in infarction. There were no persistent Type II
endoleaks related to an ARA. No patients required hemo-
dialysis during the study period. A subgroup analysis was
performed on patients with chronic renal insufficiency (de-
fined as a GFR 60 mL/hr) and solitary kidneys (11
patients in the covered group and 12 in the uncovered
group), which showed no difference in GFR change when
comparing covered with uncovered ARA cohorts. Addi-
tionally, while mean ARA diameter was approximately 3
Table III. Patient outcomes
Thirty-day mortality (%)
Survival at 24 months
Change in glomular filtration rate (mL/min)
Change in blood pressure meds (#)
Renal infarct volume (%)
Endoleak
Early
Late
Secondary interventions
aLog-rank test.
Fig 2. Change in glomerular filtration rate (GFR) (mL/min) vs
accessory renal artery (ARA) size in patients with covered (A) and
uncovered (B) ARAs.mm, there was great variability around the change in GFR pt each ARA size (Fig 2). No association was noted, how-
ver, between GFR deterioration and increasing ARA size
R2  0.002, P  .762 for covered and R2  0.026, P 
397 for preserved ARAs, respectively). In particular, 10
25%) patients with covered ARAs had arterial diameters
arger than that suggested for coverage by the Society of
ascular Surgeons Guidelines (3 mm)7 without a trend
oward worsening renal function (Fig 2). Finally, an addi-
ional linear regression model was generated comparing
hange in GFR over time versus percent renal infarction,
hich failed to demonstrate a significant trend (R2 
.053, P  .164).
ISCUSSION
The findings reported here support the coverage of
RAs when necessary during EVAR using a wide comple-
ent of devices, even in patients with chronic renal insuf-
ciency. In contrast to published guidelines,7 these results
lso suggest that, when necessary, coverage of ARAs larger
han 3 mm can be done safely in certain circumstances (Fig
). We cannot offer recommendations as to absolute con-
raindications to coverage and threshold GFR levels in lieu
f considering cases individually. This report contains a
arge contemporary group of patients subject to the most
urrent endovascular techniques and devices. The propor-
ion of patients in our series requiring ARA coverage is
onsistent with the larger population at risk, given the
revalence of ARAs. Our series is the largest of its kind to
ate and is the first to incorporate a similar control group,
RA size data, volumetric renal infarction calculations, and
n analysis of groups at higher risk for renal functional
eterioration.
The two groups compared in this series were selected
ased on the presence of an infrarenal aortic aneurysm
ith ARAs originating below the lowest renal artery. The
roups were well matched in terms of aneurysm and
atient characteristics. Moreover, subgroup analysis of
atients with chronic renal insufficiency and solitary
idneys did not show any difference in terms of renal
unctional deterioration when comparing those with
overed and uncovered ARA preservation (P  .59);
uprarenal fixation was used in just over half of the
overed
 40)
Uncovered
(n  29) P value
2.5 0 1a
(6.26) 90.1% (6.98) .1861a
(2.9) 0.7 (3.3) .4
(0.2) 1.8 (0.22) .6069
.1  1.3 0.5  0.5 .0001
(32.5) 11 (37.9) .69
(15) 2 (7) .45
(15) 5 (17.2) 1.0C
(n
85%
4.3
1.7
12
13
6
6atients in each group, and the amount of contrast and
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groups. As expected, patients with ARA coverage had
shorter aneurysm necks and thus likely benefited from a
longer seal zone. There was one death in the ARA
coverage unrelated to renal failure; however, there was
no overall difference in 30-day or 24-month survival
between the two cohorts. Importantly, there were also
no clinically significant ARA-related endoleaks; an earlier
report from White and colleagues implicated a Type II
endoleak from an ARA as the cause of a late rupture and
death, further raising concern over the management of
ARAs during EVAR.10
We found that although renal mass is commonly lost,
renal function is maintained after ARA coverage during
EVAR. In fact, 84% of patients with ARA coverage
developed detectable renal infarcts on follow-up imag-
ing. Volume of renal infarction was dramatically different
when comparing patients with ARA coverage versus
ARA preservation (P  .0001). This is in contrast to
most previous reports on ARA coverage and EVAR in
which infarction resulted in 0% to 50% of patients (Table
IV). These results suggest that ARAs generally perfuse
discrete parenchymal areas and are thus end-arteries.
Nevertheless, in most cases, renal infarction failed to
result in compromised renal function or worsening hy-
pertension, even in patients with ARAs larger than 3 mm
in diameter. Moreover, the paucity of Type II endoleaks
related to ARA coverage in this report is also consistent
with poor collateralization and thus the status of ARAs as
end arteries. Themost likely explanation for the difference in
detection of renal infarctions is related to newer imaging
technologywith higher resolutionCTangiography (cutswere
0.6 mm vs 2.5 mmminimum in previous reports) and three-
dimensional workstation reconstructions.
Four previous case series have specifically addressed
ARA coverage during EVAR11-14 (Table IV). Follow-up
ranged from 11.5 to 16 months in a total of 82 patients
with covered ARAs in all published case series. The
incidence of renal infarction with ARA coverage in pre-
vious reports is 0% to 50% without associated long-term
renal dysfunction or worsening hypertension. Impor-
Table IV. Results after coverage of accessory renal arteries
First author Year
Follow-up
(months)
ARA
coverage
patients
(n)
Control
patients (n)
Greenberg 2011 27 40 29 (preserved AR
Karmacharya 2006 16 35 26 (no accessory
ARAs)
Kim 2004 Not reported 11 8 (preserved AR
Aquino 2001 11.5 24 0
Kaplan 1999 Not reported 12 0tantly, none of these case series report Type II ARA- melated endoleaks. Compared with the previously pub-
ished reports on ARA coverage and EVAR, we believe
hat this report offers timely new insights worth empha-
izing. First, this study uniquely uses a consecutive con-
emporaneous control group of patients with ARAs eli-
ible for coverage. Second, data are presented on renal
rtery size and renal infarction volume. Third, this report
nvolves a diversity of devices, including a large percent-
ge with suprarenal fixation, with the longest follow-up
o date with precise imaging analysis.
Inherent limitations exist relating to the current study’s
ethodology, most notably the retrospective design and
onrandomized treatment arms resulting in ARA coverage
ersus preservation. However, design of a prospective ran-
omized study to assess the safety of ARA coverage is not
ery practical given the myriad of anatomic and physiolog-
cal factors involved in elective aortic aneurysm repair.
dditionally, information relating to the rationale for cov-
rage or preservation of ARAs was not readily available for
very case. The most logical explanation for cases of
lanned coverage for an ARA originating from the aneu-
ysm neck is to enhance seal length. Indeed, there was a
ifference in neck length between patients with covered
nd preserved ARAs (P  .03). Coverage of an ARA
riginating from the aneurysm itself is clearly not optional
nd would occur if the perceived risk of postoperative renal
ysfunction was minimal; this is influenced by an array of
actors such as preoperative comorbidities, renal function,
neurysm size, ARA size, presence of a contralateral well-
erfused kidney, and the risk of open surgery. Another
actor less well understood is the perceived risk of a clini-
ally significant ARA Type II endoleak, which is likely a rare
ut not inconsequential event.10 The perception of possi-
le ARA Type II endoleak was most likely the impetus
ehind preoperative embolization in two of the cases de-
cribed. The data reported here would suggest that preop-
rative embolization of ARAs prior to EVAR is unneces-
ary. Finally, limited numbers of patients in subgroup
nalyses can increase the possibility of a Type II statistical
rror and these results require additional study, probably
As) during endovascular aneurysm repair (EVAR)
Renal
infarction
patients (%)
Renal
function
deterioration
Worsening
hypertension
ARA-related
endoleak
84 (3% of control
group)
0 0 0
20 (19% of
control group)
0 0 0
0 0 0 0
21 1 (thought
unrelated)
0 (1 patient
resolved)
0
50 0 (1 patient
resolved)
0 0(AR
As)
As)ulti-institutional.
11
1
1
1
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Our study offers additional intermediate and long-term
data supporting the safety of EVAR in patients with ARAs
and supports the safety of ARA coverage in a contemporary
cohort of patients. There was no overall difference in 30-
day or 24-month survival between patients with and with-
out ARA coverage. There were no clinically significant
ARA-related endoleaks. ARA size, pre-existing renal insuf-
ficiency, or hypertension did not influence outcomes in this
series. In contrast to findings in previous reports, renal mass
is commonly lost, but renal function is maintained after
ARA coverage during EVAR. Routine surveillance contin-
ues to be important for this patient cohort to follow both
renal function and adequacy of aneurysm repair.
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Dr Jeffrey L. Ballard (Orange, Calif). Dr Greenberg and
colleagues ask the often considered question, “Can we get away
with it?” That is, what happens when one covers reasonably sized
accessory renal arteries during endovascular aneurysm repair? They
studied this consequence using outcomes such as change in eGFR,
antihypertensive medication requirements, and renal infarct vol-
ume and compared patients with ARAcoverage to those whose
ARAs were preserved. These measures would seem to be more
telling than the usual situation in open AAA repair, when small,
nonbleeding accessory or other aortic branch vessels are ligated
without trepidation and larger ones that back-bleed are reattached
because it just seems appropriate. If the creatinine doesn’t change
post-op, then we did the right thing!
As you heard, mean patient follow-up was 27 months, no
patient was lost to follow-up, and the average ARA diameter was
not insignificant at 3 mm. Although there was a significant differ-
ence in renal infarct size between covered and uncovered ARA
groups, there was no change in eGFR or antihypertensive medica-
tion requirements. Additionally, there were no persistent type II
endoleaks related to uncovered ARAs. Subgroup analysis of pa-nce in outcome when patients with covered ARAs were compared
o those with uncovered ARAs.
The take-home message of this tidy, well-analyzed, well-
ritten paper is that, in fact, we can get away with it. Some renal
ass with be sacrificed but renal function as measured will be
aintained despite ARA coverage during endograft repair of
AAs.
I have two questions for the authors:
. Did suprarenal fixation, which was performed in nearly 50% of
your study group, impact the rate or volume of renal infarct?
. How does aortic neck length factor into your decision pro-
cess? For instance, would you cover a 4-mm ARA that
supplies perfusion to 30-35% of the kidney to secure a better
seal zone, or will you protect renal mass and deploy distal to
the seemingly significant ARA and risk an incomplete prox-
imal seal?
Thank you for the opportunity to discuss this paper.
Dr Matthew W Mell. We would first like to thank Dr Ballard
or his careful review of our manuscript and for his comments and
uestions. Relating to suprarenal fixation, there was an equal distri-
ution of patients with and without suprarenal fixation in patients
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conclude that transrenal fixation had no influence on renal outcomes.
Dr Ballard raises an excellent question regarding the crux of
the accessory renal artery issue; namely, when does one compro-
mise renal volume versus proximal aortic seal? This compromise
was clearly operative in the findings reported since necks werendings reported support a more liberal approach to ARA cover-
ge, these must be mitigated by individual patient physiology and
natomy. For instance, it might be appropriate to sacrifice a signif-
cant volume of one kidney in a patient who is too high risk for
pen surgery. Regardless of the decision made, we hope that our
esults at least serve to inform the patient when a strategy involvingshorter in patients requiring ARA coverage (P  .03). While the ARA coverage is contemplated.
